Diagnostic Performance of Non-invasive Fibrosis Indexes in Hepatitis B Related Fibrosis
Journal Title: Viral Hepatitis Journal - Year 2020, Vol 26, Issue 2
Abstract
Objectives: The aim of this study was to evaluate the diagnostic performance of non-invasive fibrosis markers [AST to platelet ratio (APRI), Fibrosis Index based on four factors (FIB-4) İndex, AST/platelet/GGT/Alpha-fetoprotein (AFP) Index (APGA), FI, Fibro-quotient (FibroQ), AST/ALT ratio (AAR), GGT/Platelet ratio (GPR), Platelet-age-phosphatase- AFP-AST (PAPAS) and S-Index] in chronic hepatitis b (CHB) patients. Materials and Methods: Treatment naive CHB patients who underwent liver biopsy were screened. Four hundred seventeen patients were included in the study. Fibrosis stage was reevaluated according to ISHAK score. The diagnostic efficacy of non-invasive fibrosis indicators for significant fibrosis (≥F3) and cirrhosis (≥F5) was evaluated. The diagnostic performance of the non-invasive markers was defined as the AUROC value of ≥0.9 as excellent, 0.9> AUROC ≥0.8 as good, 0.8> AUROC ≥0.7 as moderate and AUROC <0.7 as poor. Results: AUROC values of S-index, GPR, APRI, FIB-4 index, FibroQ and PAPAS for diagnosing significant fibrosis were 0.683, 0.667, 0.679, 0.679, 0.585, 0.606 respectively. AUROC values of S-Index, GPR, APGA and FIB-4 index, APRI, FibroQ, PAPAS, FI for diagnosing cirrhosis were 0.841, 0.833, 0.819, 0.802, 0.767, 0.700, 0.697, 0.620 respectively. Conclusion: Diagnostic performance of S-Index for diagnosing cirrhosis and significant fibrosis was found superior to other indexes, but diagnostic performance of all these indexes was poor in predicting significant fibrosis. Diagnostic performance of S-Index, APGA, GPR, and FIB-4 index were good in determining cirrhosis.
Authors and Affiliations
Süleyman Sayar, Roni Atalay, Şüheda Çakmak, Gülçiçek Ayrancı, Kemal Kürbüz, Resul Kahraman, Zuhal Çalışkan, Oğuzhan Öztürk, Hakan Demirdağ, Gupse Adalı, Kamil Özdil, Hamdi Levent Doğanay
Keywords
Related Articles
- EP ID EP688804
- DOI 10.4274/vhd.galenos.2020.2019.0038
- Views 109
- Downloads 0
How Aware are We of the Immune Status of Hepatitis B and Hepatitis A in Chronic Hepatitis C Patients? A Multicenter Retrospective Study from Turkey
Objectives: Patients with chronic hepatitis C virus (HCV) infection and superinfection by hepatitis A or hepatitis B virus have higher morbidity and mortality when compared with those without HCV infection. The aim of th...
Evaluation of Health-Related Life Quality of Patients with Chronic Hepatitis Admitted to a Medical Faculty Hospital
Objectives: The aim of this study was to determine the life quality and related factors of patients with chronic hepatitis B and C who admitted to the Infectious Diseases Clinic of Erciyes University Medical Faculty Hosp...
Direct-acting Antiviral Therapy for Mixed Genotype Chronic Hepatitis C Infection
Objectives: Literature data concerning the outcomes of direct acting antiviral (DAA) therapy in mixed genotype hepatitis C virus (HCV) infections are very limited, and the incidence of mixed HCV infection in Turkey is un...
Examination of Mutations in the HBsAg and Polymerase Genes Induced by Pegylated Interferon Alpha and Oral Antivirals Used in the Treatment of Chronic Hepatitis B
Objectives: The Hepatitis B Virus is a virus having high mutation frequency due to having a high replication capacity and not having error correction capability in reverse transcription.It is aimed to examine the mutatio...
Comparison of Liver Histopathology with Non-invasive Inflammation Markers as Neutrophil-lymphocyte Ratio, Platelet-lymphocyte Ratio and Mean Platelet Volume in Chronic Hepatitis B Patients
Objectives: Platelet-lymphocyte ratio (PLR) and neutrophillymphocyte ratio (NLR) are commonly studied non-invasive inflammatory markers in cancer patients. There are some studies showing its association with fibrosis in...